Posts

The near year-long infant formula shortage in the United States that prompted the intervention of the White House is likely to “persist” until spring, according to Reckitt Benckiser, the maker of what is now the biggest brand in the market, Enfamil.

Intravacc will develop a prophylactic vaccine based on its proprietary outer membrane vesicles (OMV) platform technology.